1. |
Zhang Y, Proenca R, Maffei M. Positional cloning of the mouse obese gene and its human homologue. Nature, 1994, 372:425-432.
|
2. |
Ghilardi N, Skoda RC. The leptin receptor activates Janus kinase and signals for proliferation in a factor-dependent cell line. Mol Endocrinol, 1997, 11(4):393-399.
|
3. |
Xu FP, Chen MS, Wang YZ, et al. Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes. Circulation, 2004, 110:1269-1275.
|
4. |
侯宁,罗建.PPAR-α在瘦素诱导心肌细胞肥大中的作用. 广东医学, 2011, 9:1092-1095.
|
5. |
Matsui H, Mot ooka M, Koike H, et al. Ischemia/reperfusion in rat heart induces leptin and leptin receptor gene expression. Life Sci, 2007, 80(7):672-680.
|
6. |
Madani S, De Girolamo S, Munoz DM, et al. Direct effects of leptin on size and extracellular matrix components of human pediatric ventricular myocytes. Cardiovasc Res, 2006, 69:716-725.
|
7. |
Barouch LA, Berkowitz DE, Harrison RW, et al. Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation, 2003, 108(6):754-759.
|
8. |
Smith CC, Mocanu MM, Davidson SM, et al. Leptin, the obesity-associated hormone, exhibits direct cardioprotective effects. Br J Pharmacol, 2006, 149(1):5-13.
|
9. |
Hausenloy DJ, Tsang A, Yellon DM. The reperfusion injury salvage kinase pathway:a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc Med, 2005, 15(2):69-75.
|
10. |
Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin:a protein secreted by visceral fat that mimics the effects of insulin. Science, 2005, 307:426-430.
|
11. |
Kawano H, Do YS, Kawano Y, et al. Angiotensin Ⅱ has multiple profibrotic effects in human cardiac fibroblasts. Circulation, 2000, 101(2078):1130-1137.
|
12. |
Matsubara H. Pathophysiological role of angiotensin-Ⅱ type 2 receptor in cardiovascular and renal diseases. Circ Res, l 998, 83(10):1182-1191.
|
13. |
常亮. 内脂素在心肌细胞肥厚和炎症反应中的作用及其机制. 石家庄:河北医科大学, 2012.12-98.
|
14. |
Hori M, Nishida K. Oxidative stress and left ventricular remodelling after myocardial infarction. Cardiovasc Res, 2009, 81(1):457-464.
|
15. |
Denzel MS, Scimia MC, Zumstein PM, et al. T-cadherin is critical for adiponectin-mediated cardioprotection in mice. J Clin Invest, 2010, 120(12):4342-4352.
|
16. |
Marso SP, Mehta SK, Frutkin A, et al. Low adiponectin levels are associated with atherogenic dyslipidemia and lipid-rich plaque in nondiabetic coronary arteries. Diabetes Care, 2008, 31(5):989-994.
|
17. |
Mitsuhashi H, Yatsuya H, Tamakoshi K, et al. Adiponectin level and left ventricular hypertrophy in Japanese men. Hypertension, 2007, 49(6):1448-1454.
|
18. |
Liao Y, Takashima S, Maeda N, et al. Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism. Cardiovasc Res, 2005, 67:705-713.
|
19. |
Shibata R, Ouchi N, Ito M, et al. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med, 2004, 10(12):1384-1389.
|
20. |
Yamauchi T, Kamon J, Ito Y, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature, 2003, 423(6941):762-769.
|
21. |
Das S, Otani H, Manlik N, et al. Redox regulation of angiotensin II preconditioning of the myocardium requires MAP kinase signaling. J Mol Cell Cardiol, 2006, 41(2):248-255.
|
22. |
Essick EE, Ouchi N, Wilson R M, et al. Adiponectin mediates cardio-protection in oxidative stress-induced cardiac myocyte remodeling. Am J Physiol Heart Circ Physiol, 2011, 301(3):984-993.
|
23. |
Ohashi K, Kihara S, Ouchi N,et al. Adiponectin replenishment ameliorates obe-sity-related hypertension. Hypertension, 2006, 47 (6):1108-1116.
|
24. |
Gao F, Gao E, YUE TL, et al. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion:the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphoryla-tion. Circulation, 2002, 105(12):1497-1502.
|
25. |
Patel L, Buckels AC, Kinghhorn IJ, et al. Resistin is expressed in human macrophages and directly regulated by PPARg activators. Biochem Biophys Res Commun, 2003, 300(2):472.
|
26. |
王新成, 李国庆. 抵抗素的研究进展. 现代生物医学进展, 2010, 26(1):3598-3600.
|
27. |
Chemaly ER, Hadri L, Zhang S, et al. Long-term in vivo resistin overexpression induces myocardial dysfunction and remodeling in rats. J Mol Cell Cardiol, 2011, 51(2):144-155.
|
28. |
McManus DD, Lyass A, Ingelsson E, et al. Relations of circulating resistin and adiponectin and cardiac structure and function:the framingham offspring study. Obesity (Silver Spring), 2012, 20(9):1882-1886.
|
29. |
Gao J, Chang C, Chen Z, et al. Resistin, an adipocytokine, offers protection against acute myocardial infarction. Mol Cell Cardiol, 2007, 43(5):601-609.
|
30. |
Smith CC, Lim SY, Wynne AM, et al. Failure of the adipocytokine, resistin, to protect the heart from schemia reperfusion injury. Cardiovasc Pharmacol Ther, 2011, 16(1):63-71.
|
31. |
Yang RZ, Lee MJ, Hu H, et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue:possible role in modulating insulin action. Am J Physiol Endocrinol Metab, 2006, 290(6):E1253-E1261.
|
32. |
Fain JN, Sacks HS, Buehrer B, et al. Identification of omentin mRNA in human epicardial adipose tissue:comparison to omentin in subcutaneous, internal mammary artery periadventitial and visceral abdominal depots. Int J Obes(Lond), 2008, 32(5):810-815.
|
33. |
Schaffler A, Neumeier M, Herfarth H, et al. Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochem Biophys Acta, 2005, 1732(1-3):96-102.
|
34. |
Suzuki Y, Shin K, Lonnerdal B. Molecular cloning and functional expression of a human intestinal lactoferrin receptor. Biochemistry, 2001, 40(51):15771-15779.
|
35. |
Yamawaki H, Kuramoto J, Kameshima S, et al. Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Bichem Biophys Res Commun, 2011, 408(2):339-343.
|
36. |
Tan BK, Adya R, Farhatullah S, et al. Metformin treatment may increase omentin-1 levels in women with polycystic ovary syndrome. Diabetes, 2010, 59(12):3023-3031.
|
37. |
石翠翠, 张昕. 脂肪因子与心血管疾病的研究进展. 中国循环杂志, 2014, (10):858-860.
|
38. |
Gao X, Mi S, Zhang F, et al. Association of chemerin mRNA expre-ssion in human epicardial adipose tissue with coronary atherosc-lerosis. Cardiovasc Diabetol, 2011, 10:87.
|
39. |
Rhee EJ. Chemerin:A Novel Link between Inflammation and Atherosclerosis? Diabetes Metab J, 2011, 35(3):216-218.
|
40. |
Ernst MC, Haidl ID, Zuniga LA, et al. Disruption of the chemokine-like receptor-1(CMKLR1) gene is associated with reduced adiposity and glucose intolerance. Endocrinology, 2012, 153(2):672-682.
|